NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

NOVO.B.DK

240.4

+1.22%↑

GMAB.DK

1,795

-0.28%↓

HLUNB.DK

40.4

+1.61%↑

ZEAL.DK

286.7

-2.98%↓

AMBUB.DK

65.3

+1.48%↑

Search

Coloplast A-S (Class B)

Fechado

430 1.9

Visão Geral

Variação de preço das ações

24h

Atual

Mín

422.1

Máximo

434.9

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.41

66.418

EPS

6.32

Rendimento de Dividendos

5.19

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.19%

2.36%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-21B

97B

Abertura anterior

428.1

Fecho anterior

430

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de abr. de 2026, 17:04 UTC

Grandes Movimentos do Mercado

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 de abr. de 2026, 00:00 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Big Yachts, Big Bucks -- Barrons.com

10 de abr. de 2026, 21:55 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 de abr. de 2026, 21:01 UTC

Ganhos

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

10 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Basic Materials Roundup: Market Talk

10 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

10 de abr. de 2026, 20:31 UTC

Conversa de Mercado

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 de abr. de 2026, 20:10 UTC

Aquisições, Fusões, Aquisições de Empresas

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 de abr. de 2026, 19:15 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

10 de abr. de 2026, 19:15 UTC

Conversa de Mercado

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 de abr. de 2026, 19:08 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 de abr. de 2026, 19:08 UTC

Conversa de Mercado

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 de abr. de 2026, 18:38 UTC

Conversa de Mercado

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 de abr. de 2026, 18:25 UTC

Conversa de Mercado
Notícias Principais

Precious Metals Finish With Weekly Gains -- Market Talk

10 de abr. de 2026, 18:05 UTC

Conversa de Mercado

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 de abr. de 2026, 17:31 UTC

Conversa de Mercado
Notícias Principais

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 de abr. de 2026, 17:26 UTC

Ganhos

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 de abr. de 2026, 17:10 UTC

Conversa de Mercado

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 de abr. de 2026, 17:00 UTC

Notícias Principais

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 de abr. de 2026, 16:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

10 de abr. de 2026, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

10 de abr. de 2026, 16:12 UTC

Ganhos

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 de abr. de 2026, 16:11 UTC

Ganhos

Partners Group: Traditional Programs Contributed $3.3B

10 de abr. de 2026, 16:10 UTC

Ganhos

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 de abr. de 2026, 16:10 UTC

Ganhos

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 de abr. de 2026, 16:10 UTC

Ganhos

Partners Group 1Q New Client Demand $8.3B

10 de abr. de 2026, 16:09 UTC

Ganhos

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 de abr. de 2026, 15:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Plenitude Completes Acquisition of Acea Energia

10 de abr. de 2026, 15:38 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat